García-Alonso Claudia Angélica, Jiménez-López Brenda, Castaño-Duque Sebastián, Yepes-Nuñez Juan José, Lampousi Anna-Maria, Sánchez-Salguero Erick, Brunck Marion E G
Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Monterrey, Mexico.
Hospital Universitario San Ignacio, Bogota, Colombia.
BMJ Open. 2025 Mar 26;15(3):e091323. doi: 10.1136/bmjopen-2024-091323.
The immunological composition of breastmilk has gained research interest as breastfeeding has been persistently correlated with improved health outcomes in children. Immune cells, also known as leucocytes, are key components of the body's immune system, but they remain understudied in breastmilk. The relevance of breastmilk leucocytes for breastfeeding-mediated immune benefits remains controversial. To identify the current state-of-the-art on breastmilk leucocyte research, unearth knowledge gaps and propose research priorities, a scoping review is necessary.
This scoping review will address the general question of what is known about leucocytes in human breastmilk. The development of this scoping review protocol adhered to the recommendations set forth by the Joanna Briggs Institute guidelines. Peer-reviewed research articles published in English, French or Spanish will be eligible for inclusion in the scoping review. The initial literature search was conducted in January 2024 within the Medline, Embase, Cochrane Central and BVS databases.
This review does not require ethics approval. Our dissemination strategy includes peer-review publication and presentations at conferences and to relevant stakeholders.
This protocol was registered in Open Science Framework (available at: https://osf.io/kwfsy) on 19 February 2024.
母乳的免疫成分已引起研究关注,因为母乳喂养一直与儿童更好的健康结果相关。免疫细胞,也称为白细胞,是人体免疫系统的关键组成部分,但它们在母乳中的研究仍较少。母乳白细胞对母乳喂养介导的免疫益处的相关性仍存在争议。为了确定母乳白细胞研究的当前最新状况,找出知识空白并提出研究重点,有必要进行一项范围综述。
本范围综述将探讨关于人母乳中白细胞已知情况的一般问题。本范围综述方案的制定遵循了乔安娜·布里格斯研究所指南提出的建议。以英文、法文或西班牙文发表的经过同行评审的研究文章将有资格纳入范围综述。初步文献检索于2024年1月在Medline、Embase、Cochrane Central和BVS数据库中进行。
本综述无需伦理批准。我们的传播策略包括同行评审发表以及在会议上向相关利益攸关方进行展示。
本方案于2024年2月19日在开放科学框架(可在https://osf.io/kwfsy获取)中注册。